Myriant has vaildated that high value biochemicals can be commercially produced at prices competitive with their oil-based counterparts.  The company has an extensive pipeline of products ranging from the discovery through piloting stage.

All products in the pipeline have large current markets and can be produced directly via fermentation or are derivatives one step down in the value chain.  They have large substitute markets that support rapid market acceptance.